• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. 3rd Party
  1. “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata

    “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata

  2. Cell-based Assays Market to Reach $19.9 Billion by 2022: Key Players are Becton, Dickinson and Company, Cisbio Bioassays, PerkinElmer & Danaher Corporation - Research and Markets

    Cell-based Assays Market to Reach $19.9 Billion by 2022: Key Players are Becton, Dickinson and Company, Cisbio Bioassays, PerkinElmer & Danaher Corporation - Research and Markets

  3. $934 Million Mycoplasma Testing Market 2017 by Product & Services, Technique, Application, and End User - Global Forecast to 2022 - Research and Markets

    $934 Million Mycoplasma Testing Market 2017 by Product & Services, Technique, Application, and End User - Global Forecast to 2022 - Research and Markets

  4. Medidata Schedules Second Quarter Earnings Conference Call for July 18, 2017

    Medidata Schedules Second Quarter Earnings Conference Call for July 18, 2017

  5. Smithers Viscient Names Larry Brewer North American Technical Director, Adds Glen (Gus) Zieske as Director of Avian and Wildlife Toxicology

    Smithers Viscient Names Larry Brewer North American Technical Director, Adds Glen (Gus) Zieske as Director of Avian and Wildlife Toxicology

  6. Japanese CRO Market Overview 2017 - Research and Markets

    Japanese CRO Market Overview 2017 - Research and Markets

  7. Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

    Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

  8. Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

    Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

12345

©2017 Morningstar Advisor. All right reserved.